Takahiro Kodama

52PUBLICATIONS
90CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Aug 02, 2026
Serum Agalactosyl IgG Predicts Hepatocellular Carcinoma and All-Cause Mortality After SVR in Advanced Chronic Hepatitis C.

|Jul 11, 2026
Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin-3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.

|Apr 09, 2026
Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Yu Sato, Takahiro Kodama, Kazuki Maesaka

|Mar 30, 2026
Systemic immune profiling uncovers divergent mechanisms and predictive biomarkers of response to combination immunotherapies in hepatocellular carcinoma.

Akira Nishio, Takahiro Kodama, Kazuma Daiku

|Mar 24, 2026
Impact of Treatment Response to Anticoagulant Therapy on Liver-Related Events in Patients With Cirrhosis and Portal Vein Thrombosis.

Atsushi Maeda, Yuki Tahata, Hayato Hikita

|Feb 09, 2026
Post-to Pretreatment Ratio of Serum CXCL10 Level Predicts Short-Term Liver Function Outcome in Compensated and Decompensated Cirrhotic Patients Due to Chronic Hepatitis C Virus Infection After Direct-Acting Antiviral Therapy.

Takanori Suzuki, Kentaro Matsuura, Yuki Tahata

Pageof 9

Frequent Collaborators

27 joint publications

Ryotaro Sakamori

24 joint publications

Tetsuo Takehara

21 joint publications

Hayato Hikita

13 joint publications

Kazuhiro Murai